Prevalence of heterophilic antibodies in serum samples from horses in an equine hospital, and elimination of interference using chicken IgY by Dong, Bo et al.
Dong et al. Acta Vet Scand           (2021) 63:10  
https://doi.org/10.1186/s13028-021-00575-1
RESEARCH
Prevalence of heterophilic antibodies 
in serum samples from horses in an equine 
hospital, and elimination of interference using 
chicken IgY
Bo Dong1,2, Daniel Bergman1 and Bodil Ström Holst1* 
Abstract 
Background: Heterophilic antibodies in serum and plasma can interfere with mammalian antibodies in immunoas-
says and result in false test results, usually false positive. Although studies screening for heterophilic antibodies as well 
as elimination studies have been conducted in dogs and cats, knowledge of the presence of heterophilic antibodies 
in other species in veterinary medicine is limited. In this study, a 2-site sandwich-type interference assay that detects 
anti-mouse antibodies was used to detect heterophilic antibodies in a population of horses treated in an animal 
hospital.
Results: A total of 194 serum samples from 127 individual horses were analyzed. There were 11/127 (8.7%) interfer-
ence-positive horses, and these were analyzed in an assay exchanging the capture mouse IgG with chicken IgY. The 
positive samples were negative in the chicken IgY assay, indicating elimination of a possible interference, with the 
chicken-based assay. Four interference-positive samples were from geldings, and anti-Müllerian hormone (AMH) was 
analyzed from these samples. AMH concentrations were negative in these samples as expected in geldings, indicating 
that the heterophilic antibodies did not cause interference in the AMH assay.
Conclusion: The present study shows that there are heterophilic antibodies in horse serum samples like in samples 
from humans, dogs, and cats. The use of chicken-based reagents, such as chicken IgY, which do not cross-react with 
mammalian IgG, eliminates the effects of interfering antibodies in the samples. Equine heterophilic antibodies do not 
necessarily cause interference in commercial immunoassays.
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Background
Immunoassays are commonly used in veterinary clinical 
practice, especially for hormone analyses, and provide 
support for clinical diagnosis and treatment. One assay 
that is commonly used is the sandwich immunoassay [1]. 
This assay has the advantage of being very sensitive, but 
it is also prone to interference by heterophilic antibodies 
[1]. Heterophilic antibodies can cross-link capture anti-
bodies with detection antibodies and have been shown to 
cause false-positive results in human medicine [2–7], for 
anti-Müllerian hormone (AMH) and B-type natriuretic 
hormone in dogs [8, 9], and for equine growth hormone 
(eGH) in horses [10, 11]. In human medicine, hetero-
philic antibodies can be grouped as true heterophilic 
antibodies, human antimouse antibodies (HAMA) and 
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Reported prevalences of heterophilic antibodies vary 
and depend on methods used. A double-antibody sand-
wich immunoassay that does not cross-link with any 
known substance can be used to screen for heterophilic 
antibodies. In such an assay, signals may be generated by 
the cross-linking of the assay antibodies by heterophilic 
antibodies [1]. In veterinary medicine, an interference 
assay was used to study the prevalence of heterophilic 
antibodies in the serum of dogs and cats, and the preva-
lence was reported to be 5–9% [13]. In horses, it has been 
reported to be 5% [11]. In humans, it has been reported 
to be as high as 40% [14]. The frequency of interference 
in human serum samples has been reported to be from 
0.5 to 2% to around 4% [15, 16]. It will vary with the assay 
used but will be lower than the prevalence of heterophilic 
antibodies [8, 16].
Most previous reports on screening and elimination 
of interfering antibodies in veterinary clinical labora-
tories have focused on dogs and cats [9, 13, 15]. In the 
horse, abnormally high concentrations of eGH analyzed 
using an in-house enzyme-linked immunosorbent assay 
(ELISA) have been described to be caused by heterophilic 
antibodies, and a screening revealed a presence of heter-
ophilic antibodies in 5% of serum samples from healthy 
horses [10, 11].
Heterophilic antibodies are a heterogeneous group, and 
multiple strategies are required to eliminate their effect 
on assay results [17]. One approach is taking advantage of 
the fact that heterophilic antibodies against mammalian 
IgG do not cross-react with chicken IgY. The exchange of 
mouse IgG with chicken IgY has therefore been shown to 
eliminate the interference of heterophilic antibodies in 
human samples as well as in samples from dogs and cats 
[13, 18].
The goals of this study were to use a previously devel-
oped species-independent interference assay to screen 
a population of horses treated in animal hospitals for 
presence of heterophilic antibodies, to assess whether 
chicken IgY-based tests eliminate interference and if 
detected heterophilic antibodies cause interference in a 
commercial sandwich immunoassay for analysis of AMH.
Methods
Animals
Equine serum that had been analyzed at the Clinical 
Pathology Laboratory, the University Animal Hospital 
in Uppsala, Swedish University of Agricultural Sciences, 
Sweden was used. Exclusion criteria were clearly visible 
signs of hemolysis or lipemia.
Interference assay
An interference assay was performed as described 
by Bergman and co-workers [13]. Negative samples 
from trial runs were pooled and used as negative con-
trols. The chicken anti-mouse IgG was diluted 1:1600 
in the pooled negative control sera and this solution 
represented the positive control. As standard, chicken 
anti-mouse IgG (Immunsystem AB, Uppsala, Sweden) 
was used, diluted in phosphate-buffered saline (PBS) 
1:1600. The cutoff point was determined by calculat-
ing the mean optical density (OD) of the duplicates of 
a serial dilution seven times of the standard. For each 
run, the cutoff point was required to be greater than 
the assay limit of detection (LoD), as determined by the 
formula LoD = 0-standard + 2 standard deviations (SD) 
(doing 25 repeat measurements of the 0-standard). The 
intra-assay coefficients of variation (CVs) for the cutoff 
point ranged from 0.88 to 6.81%, and the inter-assay 
CV was 22.1%. A relative OD value for each sample was 
calculated by dividing the mean OD of the sample by 
the cutoff value. The cutoff limit for a positive result 
was > 1. Similarly, the positive control was required to 
be > 1 and the negative control < 1.
In brief, 100  µL purified mouse IgG (2  µg/mL) was 
added to each well of a polystyrene microtiter plate 
and placed overnight at 4  ºC. After washing with PBS, 
a total volume of 50 µL of standards, controls and sam-
ples were pipetted in duplicate into the wells followed 
by incubation at room temperature (RT). After another 
washing, monoclonal horseradish peroxidase (HRP)-
conjugated mouse anti-human carcinoembryonic anti-
gen (CEA) IgG was added, selected not to match the 
specificity of the capture antibody, thereby excluding 
the possibility that any existing analyte would give rise 
to a positive result. The plate was then incubated and 
washed. Finally, 3,3ʹ,5,5ʹ tetramethylbenzidinen (TMB) 
was added and the plate was incubated for 8 min at RT 
in the dark before adding stop solution  (H2SO4) and 
reading OD at 450 nm.
Interference elimination
Samples that were positive in the interference assay 
were further tested in a chicken-based assay, as previ-
ously described [13]. In brief, every second column of 
a microtiter plate was coated with either 2  µg/mL of 
purified mouse IgG or 2 µg/mL nonimmunized chicken 
IgY (Immunsystem AB). 50  µL of standards, controls 
and samples were added into each well, and incubated 
at RT. After washing, 100  µL of a 1:10,000 dilution of 
monoclonal HRP-conjugated mouse anti-human CEA 
IgG was added, followed by incubation at RT. The plate 
was washed, TMB was added and the plate was incu-
bated at RT in the dark before adding stop solution and 
reading OD at 450 nm.
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Anti‑Müllerian hormone assay
Samples from geldings that were positive in the inter-
ference assay were analyzed for AMH using an ELISA 
(AMH Gen II, Beckman coulter), according to the man-
ufacturer. Briefly, 30 µL of standards, controls and sam-
ples were mixed with 150  µL assay buffer, and 120  µL 
of the so achieved solution were pipetted in duplicate 
into each well and incubated in an anti-AMH antibody 
coated microtitration plate. After incubation and wash-
ing, anti-AMH biotin conjugate was added, and after a 
second incubation and washing step, streptavidin-HRP 
was added. After a third incubation and washing step, the 
substrate, TMB, was added and incubated briefly before 
adding an acidic stopping solution. The degree of enzy-
matic turnover of the substrate was determined by dual 
wavelength absorbance measurement at 450  nm and 
620 nm. The intra-assay CV was < 5% and the inter-assay 
CV was < 15%.
Statistical analysis
Routine descriptive statistical methods were used. The 
effects of sex, breed, castration status and diagnosis were 
compared between the positive and the negative group 
using Student’s t-test. In the study of interference elimi-
nation, the Wilcoxon signed-rank test was used to com-
pare results using mouse IgG with those using chicken 
IgY. The level of statistical significance was set at P < 0.05. 
The GraphPad Prism Software version 8.0 for Windows 
(San Diego, CA, USA) was used for statistical analyses.
Results
Horses
A total of 194 samples from 127 individual horses were 
analyzed. The horses were of 27 different breeds. Their 
median age was 8  years, interquartile range (IQR) 0.5–
13.0  years, and included 59 mares, 22 stallions and 46 
geldings. Forty-four horses were subjected to multiple 
analyses: 27 horses had samples analyzed twice, 10 horses 
three times, 5 four times and two horses had samples 
analyzed 5 times. All multiple samples were collected at 
different times. The horses were classified into 9 differ-
ent categories according to diagnosis or cause for initial 
sampling (Table 1).
Interfering antibodies in horses
There were 11/127 (8.7%) interference-positive horses, 
with a median age of 12.0 years, range 1 month–17 years, 
(IQR 4.0–15.0  years), seven mares and four geldings of 
seven different breeds (Fig. 1).
The relative OD for the positive samples ranged 
between 1.01 and 4.69. A 15-year-old Icelandic horse 
gelding admitted to the animal hospital for liver disease 
was sampled three times within two weeks and was only 
positive for interference the second time (relative OD 
1.2). A 14-year-old intact female Icelandic horse with a 
subcutaneous skin abscess was positive for interference 
Table 1 Characterization of the horses screened for interfering antibodies by disease category
Disease category Positive samples (n = 11) % Negative samples (n = 116) % Total (n = 127)
Bone, muscle and joint 4 21.1 15 78.9 19
Digestive tract 2 3.9 49 96.1 51
Infection/inflammation 2 9.5 19 90.5 21
Neoplastic disease 1 16.7 5 83.3 6
Neurologic disease 0 0 4 100 4
Reproductive disease 0 0 5 100 5
Respiratory disease 0 0 3 100 3
Skin disease 1 10 9 90 10
Other 1 16.7 5 83.3 6
SUM 11 8.7 116 91.3 127
Fig. 1 Screening results of interference assay. Horse samples 
(n = 127) were screened with a sandwich ELISA using nonimmunized 
mouse IgG as the capture antibody. Cutoff level is indicated by the 
dashed horizontal line
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the first sample (relative OD 1.03), but was negative on 
three subsequent samplings within three weeks. There 
was no significant difference of age, sex, breed, neutering 
status, or diagnostic category between interference-posi-
tive and interference-negative horses (P > 0.05).
Interference elimination
When chicken IgY antibody was used as the capture anti-
body, all the 11 interference-positive samples were nega-
tive. When mouse IgG was used, five samples were also 
detected negative, although they had previously been 
evaluated positive in screening tests (Fig. 2). The 11 sam-
ples produced significantly less signal in the wells con-
taining chicken IgY than in wells containing mouse IgG 
(Z = − 3.059, P < 0.01).
Analysis of anti‑Müllerian hormone
Enough serum for AMH analysis was available from four 
geldings (relative OD 1.1; 1.2; 1.2 and 1.8), all of which 
had AMH concentrations below the lowest standard 
point.
Discussion
In the present study, equine serum samples were 
screened for heterophilic antibodies and the prevalence 
was found to be 8.7% (11/127). This is similar but slightly 
higher than previously reported for horses [11], and simi-
lar to what has been reported for cats and dogs, using the 
same species-independent ELISA [13]. The horse popu-
lation studied by Borromeo and co-workers [11] was 
healthy horses. The samples included in the present study 
were from horses admitted to an equine hospital, and the 
results may therefore better mirror the situation in clini-
cal practice. Variations in prevalence of heterophilic anti-
bodies may also be related to the methods used.
In human medicine, it has been shown that interference 
in immunoassays is a present and underestimated prob-
lem [16, 19]. The result achieved when affected by het-
erophilic antibodies is usually falsely increased, resulting 
in overestimation of the analytes in question. Examples 
of analyses that may be affected in equine medicine are 
e.g. adrenocorticotrophic hormone (ACTH) and insulin, 
used in the diagnosis of the two most common endo-
crine syndromes: pituitary pars intermedia dysfunction 
(PPID) and equine metabolic syndrome (EMS) [20], and 
erythropoietin, used for doping [21]. If the test results 
are clearly above the normal range, interference by het-
erophilic antibodies may be suspected, as was the case of 
interference with the in-house eGH ELISA [10]. In other 
cases, a result that is false high but within the normal 
range may not raise such a suspicion but lead to an incor-
rect diagnosis. Evaluating the effect of heterophilic anti-
bodies on immunoassays is challenging, as the true result 
most often is unknown. Reanalyzing the sample after 
precipitation with polyethylene glycol (PEG) can result 
in normalized values in humans [22], but the method 
does not work well for samples from dogs [8]. One assay 
with a known expected result for castrated animals is the 
AMH immunoassay. In horses, this assay can be used 
to differ geldings, having non-detectable AMH concen-
trations, from cryptorchid stallions, having high AMH 
concentrations [23]. It is a sandwich immunoassay using 
murine antibodies, and thus similar to the interference 
assay. In the present study, AMH was analyzed in sam-
ples from four geldings with heterophilic antibodies. All 
samples had AMH concentrations below the detection 
limit, thus no sign of interference was detected. One pos-
sible reason for the lack of interference, leading to false 
positive results, is that the concentrations of heterophilic 
antibodies were just above the cut-off value, indicating 
a weak reactivity. Since antibodies affect immunoassay 
results both by their concentration and their affinity, it is 
also possible that the affinity of the heterophilic antibod-
ies was too low to cause interference in the AMH assay 
[1]. In dogs, 2/7 samples with heterophilic antibodies 
caused a false positive result in the AMH assay, and these 
were the samples with the strongest anti-mouse reactiv-
ity. As commercial assays generally are designed to mini-
mize the effect of heterophilic antibodies, the problem 
with interference is expected to increase with stronger 
reactivity.
That the positive results in the interference assay were 
caused by heterophilic antibodies is supported by the 
fact that they were eliminated with chicken IgY as cap-
ture antibodies, and that samples with visible signs of 
Fig. 2 Results of interference elimination. The reactivity of 
heterophilic antibodies towards unimmunized mouse IgG and 
chicken IgY was detected with HRP- conjugated mouse anti-CEA 
antibody. The positive cutoff level is indicated by a dotted horizontal 
line
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hemolysis and lipemia were excluded. In addition, all 
samples were cryopreserved at − 20 ºC to eliminate inter-
ference by complement [24]. Clinically relevant inter-
ference has previously been described with an in-house 
ELISA for eGH using mouse and rabbit antibodies [11]. 
The lack of interference with chicken IgY suggests that 
exchanging mammalian IgG with chicken IgY in immu-
noassays may reduce the risk of interference by hetero-
philic antibodies, as has previously been described [18].
Iatrogenic interference has been reported in human 
medicine as a result of monoclonal antibody therapy [25], 
but as no therapeutic antibodies are licensed for use in 
horses this is not a possible cause for the heterophilic 
antibodies in the present study. Direct physical contact 
with other species and indirect exposure through vacci-
nation and food intake has also been suggested to poten-
tially induce heterophilic antibodies [16]. Rheumatoid 
factors are considered as one of the possible causes of the 
interference, with age, gender and autoimmunity being 
main risk factors for interference caused by RF in human 
medicine [15, 26, 27]. In horses, there have been reports 
of an age-dependent increase in IgM RF regardless of sex 
[28]. Anamnestic data from horses with positive samples 
were reviewed to identify possible risk factors for inter-
ference. However, we found no significant relationship 
between the presence of heterophilic antibodies and age, 
sex, breed, castration status, or diagnosis.
Of the 11 positive horses, three were sampled and 
assayed on multiple occasions and tested positive only 
once, with less than a month between the different sam-
ples. A transient character and low affinity of heterophilic 
antibodies has been described [29, 30], although they 
have been described to persist for several years in dogs 
[31]. The reactivity of these samples was rather weak, and 
a variation between different runs may contribute to the 
shifting results.
Conclusions
The prevalence of heterophilic antibodies in a hospi-
tal population of horses was similar to that previously 
reported for dogs and cats. Exchanging mammalian IgG 
with chicken IgY can reduce the problem of interference 
in immunoassays for equine samples.
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